Position history for Duquesne Family Office LLC's holdings in NEWAMSTERDAM PHARMA COMPANY
Duquesne Family Office LLC holds 3.1M shares of NAMS (NEWAMSTERDAM PHARMA COMPANY), worth $98,275 as of 2026-Q1. NAMS represents 2.9% of Duquesne Family Office LLC's portfolio.
Current Value
$98,275
Current Shares
3.1M
Total Value Change
+$93,502
Total Shares Change
+2.8M
Other major holders of NAMS: Capital World Investors, RA CAPITAL MANAGEMENT, L.P.
Unchanged |
| 3.1M |
0.0% |
| $98,275 |
| 2.9% |
| $30.41 |
0 |
| 2025-Q4 | Increased | 3.1M | +59.6% | $107,701 | 2.4% | $34.74 | 54 |
| 2025-Q3 | Increased | 1.9M | +131.2% | $54,710 | 1.3% | $27.52 | 53 |
| 2025-Q2 | Increased | 832,175 | +4.0% | $15,071 | 0.4% | $18.57 | 22 |
| 2025-Q1 | Increased | 800,360 | +178.3% | $16,383 | 0.5% | $21.76 | 42 |
| 2024-Q4 | Unchanged | 287,535 | 0.0% | $7,390 | 0.2% | $25.60 | 0 |
| 2024-Q3 | New | 287,535 | - | $4,773 | 0.2% | $16.23 | 25 |